SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902664-24-006498
Filing Date
2024-11-14
Accepted
2024-11-14 06:42:29
Documents
1

Document Format Files

Seq Description Document Type Size
1 ULTRAGENYX PHARMACEUTICAL INC. p24-3270sc13ga.htm SC 13G/A 61822
  Complete submission text file 0000902664-24-006498.txt   63459
Mailing Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014
Business Address 40 10TH AVENUE 7TH FLOOR NEW YORK NY 10014 646-597-6980
RTW INVESTMENTS, LP (Filed by) CIK: 0001493215 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Subject) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87964 | Film No.: 241456997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)